XINGANJIANG
873167
INNOVATIVE DATA
835305
CHENGUANG MEDICAL
430300
4
Hangzhou Gaoxin Materials Technology
300478
5
Beijing Philisense Technology
300287
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Cash cash equivalents and federal funds sold | 88.53%406.6M | 88.53%406.6M | -9.18%205.89M | 26.36%218.73M | -15.04%320.33M | 196.13%215.66M | 196.13%215.66M | 295.95%226.7M | 129.95%173.1M | 410.45%377.03M |
-Cash and cash equivalents | 88.53%406.6M | 88.53%406.6M | -9.18%205.89M | 26.36%218.73M | -15.04%320.33M | 196.13%215.66M | 196.13%215.66M | 295.95%226.7M | 129.95%173.1M | 410.45%377.03M |
Net loan | -16.06%6.21B | -16.06%6.21B | -1.36%7.33B | -0.77%7.37B | -0.58%7.43B | -0.00%7.4B | -0.00%7.4B | 3.40%7.43B | 9.71%7.43B | 26.90%7.47B |
-Gross loan | -15.99%6.25B | -15.99%6.25B | -1.37%7.37B | -0.79%7.41B | -0.60%7.47B | -0.01%7.44B | -0.01%7.44B | 3.42%7.47B | 9.72%7.47B | 26.79%7.51B |
-Allowance for loans and lease losses | -4.34%38.74M | -4.34%38.74M | -3.37%38.65M | -4.24%39.74M | -4.39%39.68M | -2.41%40.5M | -2.41%40.5M | 6.37%40M | 11.10%41.5M | 9.37%41.5M |
Securities and investments | -17.31%1.06B | -17.31%1.06B | -10.55%1.16B | -16.93%1.16B | -19.36%1.19B | -8.71%1.28B | -8.71%1.28B | -1.32%1.29B | 12.85%1.4B | 36.30%1.48B |
-Available for sale securities | -17.31%1.06B | -17.31%1.06B | -10.55%1.16B | -16.93%1.16B | -19.36%1.19B | -8.71%1.28B | -8.71%1.28B | -1.32%1.29B | 12.85%1.4B | 36.30%1.48B |
Net PPE | -11.91%47.2M | -11.91%47.2M | -9.98%48.72M | -7.88%50.35M | 1.51%56.17M | 4.71%53.58M | 4.71%53.58M | 4.66%54.11M | 0.83%54.66M | -1.66%55.33M |
-Gross PPE | ---- | ---- | ---- | ---- | ---- | 4.07%137.8M | 4.07%137.8M | ---- | ---- | ---- |
-Accumulated depreciation | ---- | ---- | ---- | ---- | ---- | -3.67%-84.22M | -3.67%-84.22M | ---- | ---- | ---- |
Foreclosed assets | -23.10%2.82M | -23.10%2.82M | 204.88%3M | 76.78%3M | 69.49%3.12M | 99.40%3.67M | 99.40%3.67M | -42.96%984K | -3.19%1.7M | 150.20%1.84M |
Goodwill and other intangible assets | -6.38%106.61M | -6.38%106.61M | -11.14%104.89M | -8.59%109.7M | -30.65%111.94M | -19.72%113.88M | -19.72%113.88M | -18.51%118.04M | -17.71%120.01M | 12.77%161.4M |
-Goodwill | -25.93%7.14M | -25.93%7.14M | ---- | ---- | ---- | -67.84%9.64M | -67.84%9.64M | -65.48%10.43M | -64.07%11.22M | 64.83%51.86M |
-Other intangible assets | -4.58%99.47M | -4.58%99.47M | -2.53%104.89M | 0.83%109.7M | 2.19%111.94M | -6.83%104.24M | -6.83%104.24M | -6.12%107.61M | -5.08%108.79M | -1.90%109.54M |
Other assets | -10.84%290.1M | -10.84%290.1M | 5.27%347.29M | 7.82%353.57M | 9.22%346.37M | 10.40%325.35M | 10.40%325.35M | 4.48%329.9M | 9.99%327.93M | 18.53%317.15M |
Total assets | -13.51%8.12B | -13.51%8.12B | -2.72%9.2B | -2.48%9.27B | -4.09%9.46B | 0.30%9.39B | 0.30%9.39B | 4.25%9.46B | 10.70%9.5B | 31.26%9.86B |
Liabilities | ||||||||||
Total deposits | -5.18%6.41B | -5.18%6.41B | -4.60%6.44B | -2.06%6.53B | -8.01%6.49B | -9.24%6.76B | -9.24%6.76B | 2.05%6.75B | 7.87%6.67B | 12.54%7.06B |
Current debt and capital lease obligation | ---- | ---- | ---- | ---- | ---- | 71.75%1.75B | 71.75%1.75B | 19.38%1.87B | 35.25%1.97B | 587.91%1.88B |
-Current debt | ---- | ---- | ---- | ---- | ---- | 71.75%1.75B | 71.75%1.75B | 19.38%1.87B | 35.25%1.97B | 587.91%1.88B |
Long term debt and capital lease obligation | 445.07%1.23B | 445.07%1.23B | 844.06%2.12B | 839.94%2.11B | 932.94%2.32B | 0.16%224.77M | 0.16%224.77M | 0.16%224.67M | 0.16%224.58M | 0.16%224.49M |
-Long term debt | 445.07%1.23B | 445.07%1.23B | 844.06%2.12B | 839.94%2.11B | 932.94%2.32B | 0.16%224.77M | 0.16%224.77M | 0.16%224.67M | 0.16%224.58M | 0.16%224.49M |
Other liabilities | -26.77%88.55M | -26.77%88.55M | -5.76%106.53M | -4.41%102.5M | -5.54%117.89M | 9.64%120.92M | 9.64%120.92M | -3.01%113.04M | -21.49%107.24M | -12.11%124.8M |
Total liabilities | -12.73%7.73B | -12.73%7.73B | -3.27%8.66B | -2.54%8.75B | -3.84%8.93B | 0.58%8.85B | 0.58%8.85B | 5.12%8.96B | 12.14%8.97B | 34.36%9.28B |
Shareholders'equity | ||||||||||
Share capital | 1.43%233.19M | 1.43%233.19M | 1.60%232.65M | 1.52%231.72M | 1.55%230.81M | 1.46%229.89M | 1.46%229.89M | 1.44%228.97M | 1.55%228.26M | 1.60%227.29M |
-common stock | 1.43%233.19M | 1.43%233.19M | 1.60%232.65M | 1.52%231.72M | 1.55%230.81M | 1.46%229.89M | 1.46%229.89M | 1.44%228.97M | 1.55%228.26M | 1.60%227.29M |
Retained earnings | -36.51%251.01M | -36.51%251.01M | -6.54%374.34M | -4.63%381.62M | -10.52%387.86M | -9.13%395.36M | -9.13%395.36M | -7.50%400.53M | -4.56%400.13M | 6.12%433.46M |
Gains losses not affecting retained earnings | -0.39%-87.2M | -0.39%-87.2M | 45.94%-68.67M | 7.49%-93.23M | -6.51%-91.34M | 12.73%-86.86M | 12.73%-86.86M | -19.91%-127.02M | -59.29%-100.77M | -177.27%-85.76M |
Total stockholders'equity | -26.26%397M | -26.26%397M | 7.13%538.32M | -1.42%520.12M | -8.29%527.33M | -4.23%538.39M | -4.23%538.39M | -9.10%502.49M | -9.15%527.62M | -4.36%574.99M |
Total equity | -26.26%397M | -26.26%397M | 7.13%538.32M | -1.42%520.12M | -8.29%527.33M | -4.23%538.39M | -4.23%538.39M | -9.10%502.49M | -9.15%527.62M | -4.36%574.99M |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |